63187-0526 Ondansetron

Product NDC:

63187-0526

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 4.0

Unit: mg/1

Packages:

Code: 63187-0526-03

Description: 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-03)

Effective Date: Feb. 1, 2019

Discontinued:

Code: 63187-0526-04

Description: 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-04)

Effective Date: Nov. 25, 2019

Discontinued:

Code: 63187-0526-05

Description: 5 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-05)

Effective Date: April 1, 2019

Discontinued:

Code: 63187-0526-06

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-06)

Effective Date: Aug. 1, 2019

Discontinued:

Code: 63187-0526-10

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-10)

Effective Date: Aug. 3, 2015

Discontinued:

Code: 63187-0526-15

Description: 15 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-15)

Effective Date: Aug. 1, 2016

Discontinued:

Code: 63187-0526-20

Description: 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-20)

Effective Date: March 1, 2019

Discontinued:

Code: 63187-0526-30

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63187-526-30)

Effective Date: Aug. 3, 2015

Discontinued:

Code: 63187-0526-12

Description: 12 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63187-526-12)

Effective Date: June 20, 2023

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC